[1] 魏来. 丙型肝炎病毒感染后的自然史[J]. 中华传染病杂志,2004,12(2):102. [2] 中华医学会肝病学分会、中华医学会传染病与寄生虫病学分会. 丙型肝炎防治指南[J]. 中华肝脏病杂志,2004,12(4):194-198. [3] HENDERSON NC,IREDALE JP. Liver fibrosis:cellular mechanisms of progression and resolution[J]. Clin Sci(lond),2007,112(5):265-280. [4] INAGAKI Y,KUSHIDA M,HIGASHI K,et al. Cell type-specific intervention of transforming growth factor beta/Smad signaling suppresses collagen gene expression and hepatic fibrosis in mice[J]. Gastroenterology,2005,129(1):259-268. [5] KISSELEVA T,BRENNER DA. Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis[J]. J Gastroenterol Hepatol,2007,22(suppl1):S73-78. [6] BATALLER R,BRENNER DA. Liver fibrosis[J]. J Clin Invest,2005,115(2):209-218. [7] SVEGLIATI-BARONI G,INAGAKI Y,RINCON-SANCHEZ AR,et al. Early response of alpha2(I) collagen to acetaldehyde in human hepatic stellate cells is TGF-beta indepengdent[J]. Hepatology,2005,42(2):343-352. [8] 陈松建,徐锡金,霍霞. 血小板衍生生长因子及其受体与疾病关系研究进展[J]. 分子生物学,2008,14(10):1441-1443. [9] 张毅,汤正好,臧国庆. 血小板衍生生长因子(PDGF)与肝纤维化[J]. 临床肝胆病杂志,2006,22(4):304-305. [10] 张连峰,田笑笑,王春峰. 转化生长因子β1和基质金属蛋白酶抑制因子-1在肝纤维化诊断中的作用及关系[J]. 中华肝脏病杂志,2007,15(4):258-260. [11] 叶军,薛冬英,张洁,等. 慢性肝炎肝纤维化患者肝组织和血清中TGF-β1、TIMP-1检测及其意义[J]. 肝脏,2007,12(4):294-295. [12] LEE SD,YU ML,CHENG PN,et al. Comparison of a 6 month course peginterferon alpha-2b plus ribavirin and interferon alpha-2a plus ribavirin in treating Chinese patients with chronic hepatitis C in Taiwan[J]. J Viral Hepat,2005,12 (3):283-291. [13] 蔺淑梅,张树林,崔杨,等. 聚乙二醇化干扰素α-2a治疗慢性丙型肝炎的疗效与安全性[J]. 中华传染病杂志,2004,22(5):348-349. [14] 胡静,李智伟,杨秀锦,等. 干扰素α对Ⅰ型胶原及转化生长因子β1基因表达的影响[J]. 中华肝脏病杂志,2009,17(9):657-660. [15] 李蕴,刘峰,徐道振,等. α干扰素治疗慢性丙型肝炎对肝纤维化的影响[J]. 肝脏,2006,11(2):119-120. [16] CHANG XM,CHANG Y,JIA A. Effects of inteferon-alpha on expression of hepatic stellate cell and transforming growth factor-beta l and alpha-smooth muscle actin in rats with hepatic fibrosis[J]. World J Gastroenterol,2005,11(7):2634-2637. |